| 期 |
栏目 |
标题 |
文件 |
| 卷 78, 编号 3 (2003) |
Editorial |
Role of some neurohumoral factors in the development of pulmonary hypertension in patients with interstitial Jung diseases |
|
| 卷 79, 编号 3 (2004) |
Editorial |
Markers of thrombophilia in pulmonary fibrosis complicated by pulmonary hypertension |
|
| 卷 79, 编号 8 (2004) |
Editorial |
Vasaprostan treatment of fibrosing alveolitis in patients withpulmonary hypertension |
|
| 卷 81, 编号 3 (2009) |
Editorial |
Estimation of plasmic concentration of the brain natriuretic peptide in interstitial pulmonary diseases with pulmonary hypertension: clinical role |
|
| 卷 81, 编号 9 (2009) |
Editorial |
Natriuretic peptides in diagnosis of pulmonary hypertension |
|
| 卷 86, 编号 8 (2014) |
Editorial |
Interstitial pulmonary fibrosis: The role of angiogenic factors, the inhibitory pathways of progression |
|
| 卷 87, 编号 3 (2015) |
Editorial |
Clinical value of surfactant protein D as a biomarker of pulmonary fibrosis in patients with scleroderma systematica in relation to the presence of gastroesophageal reflux |
|
| 卷 87, 编号 12 (2015) |
Editorial |
Current optimization of combined therapy for chronic obstructive pulmonary disease |
|
| 卷 90, 编号 1 (2018) |
Editorial |
Clinical features of cardiac lesion in patients with generalized sarcoidosis |
(Rus)
|
| 卷 90, 编号 3 (2018) |
Editorial |
Clinical significance of the determination of surfactant proteins A and D in assessing the activity of lung sarcoidosis |
(Rus)
|
| 卷 91, 编号 1 (2019) |
Editorial |
Autoimmune liver disease (primary biliary cholangitis/autoimmune hepatitis-overlap) associated with sarcoidosis (clinical cases and literature review) |
(Rus)
|
